Arthur S. Kirsch - Feb 20, 2025 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Arthur S. Kirsch
Stock symbol
AVIR
Transactions as of
Feb 20, 2025
Transactions value $
$0
Form type
4
Date filed
2/24/2025, 06:52 PM
Previous filing
Jun 24, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVIR Stock Option (Right to Buy) Award $0 +165K $0.00 165K Feb 20, 2025 Common Stock 165K $3.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in thirty-six (36) equal monthly installments following February 20, 2025 such that the option is fully vested on February 20, 2028.